国际检验医学杂志2025,Vol.46Issue(1) :32-37,43.DOI:10.3969/j.issn.1673-4130.2025.01.008

单分子实时测序在α珠蛋白基因三联体及其复合变异等位基因鉴定中的临床应用

Clinical application of the single-molecule real-time technology for identification of triplicated α-globin genes and compound variant alleles

张宇 方艳平 朱碧青 梁丽仪 周万军 江凌晓
国际检验医学杂志2025,Vol.46Issue(1) :32-37,43.DOI:10.3969/j.issn.1673-4130.2025.01.008

单分子实时测序在α珠蛋白基因三联体及其复合变异等位基因鉴定中的临床应用

Clinical application of the single-molecule real-time technology for identification of triplicated α-globin genes and compound variant alleles

张宇 1方艳平 2朱碧青 2梁丽仪 3周万军 4江凌晓2
扫码查看

作者信息

  • 1. 南方医科大学珠江医院检验医学部,广东 广州 510282;佛山市高明区人民医院检验科,广东佛山 528500
  • 2. 南方医科大学珠江医院检验医学部,广东 广州 510282
  • 3. 佛山市高明区人民医院检验科,广东佛山 528500
  • 4. 南方医科大学医学遗传学教研室,广东 广州 510515
  • 折叠

摘要

目的 探究单分子实时测序(SMRT)技术在α珠蛋白基因三联体(简称α三联体)及其复合变异等位基因鉴定中的临床应用效果.方法 收集α三联体阳性样本36例,其中经PCR-导流杂交技术确认28例、经高通量测序(NGS)技术确认8例.36例样本包含α三联体复合变异顺式或反式排列未明样本αααanti4.2复合αCSα 2例,αααanti4.2复合-α3.7 10例,HKαα/--SEA型待确证2例,均采用SMRT技术进行地中海贫血(简称地贫)基因检测.另招募一个基因型为αααanti4.2复合-α3.7变异病例的家系,包含先证者(Ⅱ-1)和其父亲(Ⅰ-1)、母亲(Ⅰ-2),采用PCR-导流杂交和SMRT技术进行地贫基因检测.结果 SMRT技术检测结果显示,36例样本中共检出35例α三联体,1例ααααanti4.2型α珠蛋白基因四联体(简称α四联体).2例αααanti4.2复合αCSα变异样本中αααanti4.2与αCSα均为反式排列,基因型为αααanti4.2/αCSα,10例αααanti4.2复合-α3.7变异样本中αααanti4.2与-α3.7为顺式排列样本9例,基因型为HKαα/αα,αααanti4.2与-α3.7为反式排列样本1例,基因型为 αααanti4.2/-α3.7.相较PCR-导流杂交技术,SMRT技术多检出1例大片段缺失型β珠蛋白基因变异和2例未知变异,阳性检出率提高10.71%(3/28).家系分析表明,先证者(Ⅱ-1)αααanti4.2和-α3.7变异均遗传自母亲(Ⅰ-2),其基因型为HKαα/αα,与SMRT技术检测结果一致.结论 SMRT技术不仅能够准确检测α三联体、α四联体及其复合变异等位基因,而且具有高准确性、一步到位识别2种变异顺式或反式排列、地贫基因变异覆盖全等优势,具有良好的临床应用价值.

Abstract

Objective To assess the clinical utility of single-molecule real-time technology(SMRT)in identifying triplicated α-globin genes and compound variant alleles.Methods A total of 36 samples with tripli-cated α-globin genes were collected.Among them,28 samples were confirmed by PCR flow-through hybridiza-tion and 8 samples were confirmed by Next Generation Sequencing(NGS).These 36 samples included tripli-cated α-globin genes compound variants with cis or trans arrangements unknown,such as αααanti4 2 compoundαcsα(2 cases),αααanti4.2 compound-α3.7(10 cases),and HKαα/--SEA pending confirmation(2 cases),SMRT technology was employed to detect thalassemia gene variants.Additionally,a pedigree with the genotype ofαααanti4.2 compound-α3.7 variant was recruited,including the proband(Ⅱ-1),its father(Ⅰ-1),and mother(Ⅰ-2).PCR flow-through hybridization and SMRT were employed to detect thalassemia gene variants.Results SMRT detected 35 out of 36 samples with triplicated α-globin genes,and 1 sample with quadrupllcated α-globin genes(ααααanti4.2).Among the 2 αααanti4 2 compound αCSα variant samples,both αααanti42 and αCSα were arranged in trans,with a genotype of αααanti4.2/αCSα.Among the 10 αααanti4.2 compound-α3.7 variant samples,9 samples hadαααanti4.2 and-α3.7 in a cis arrangement,with a genotype of HKαα/αα,and 1 sample had αααannti4.2 and-α3.7 in a trans arrangement,with a genotype of αααanti4.2/-α3.7.Compared with PCR flow-through hybridization,SMRT detected one case of a large segment deletion in the β-globin gene and two unknown variants,which led to an increase in the positive detection rate of approximately 10.71%(3/28).The pedigree analysis showed that the proband(Ⅱ-1)inherited αααanti4.2 and-α3.7 variants from his mother(Ⅰ-2),with a genotype of HKαα/αα,con-sistent with the SMRT detection results.Conclusion SMRT can accurately detect triplicated or quadrupllcat-ed α-globin genes,and compound variant alleles.It offers high accuracy,enables one-step identification of cis or trans arrangements,and provides comprehensive coverage of thalassemia gene variations,demonstrating its significant clinical value.

关键词

α珠蛋白基因三联体/HKαα/单分子实时测序/PCR-导流杂交技术/高通量测序

Key words

triplicated α-globin genes/HKαα/single-molecule real-time technology/PCR flow-through hybridization/next generation sequencing

引用本文复制引用

出版年

2025
国际检验医学杂志
重庆市卫生信息中心

国际检验医学杂志

影响因子:1.013
ISSN:1673-4130
段落导航相关论文